CLINICAL_TRIALS
trial_result
· 2022-03-24
Clinical Trial Update: Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans [Phase 3]
Summary
Phase 3 clinical trial of TY027 for COVID-19 has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tychan Pte Ltd. | Conditions: Coronavirus Disease-2019 (COVID-19) | Phase 3 | Status: TERMINATED